McDonnell Boehnen Hulbert & Berghoff LLP partner Dr. Andrew Williams authored an article entitled, “Can SCOTUS solve the biosimilar ‘enigma’?” that appears in the March 2017 online edition of intellectual Property Magazine. The Supreme Court has agreed to unpick the ‘mystery’ of the BPCIA, but will the biosimilar community get the clarity it desires? view the article
